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Several studies have indicated the important role of thymic environment, in which 
T  cells differentiate and mature, in imposing the H-2 restriction on T  cells (1). These 
findings  were incorporated  by Katz et  al.  (2)  into  the  framework of his  "adaptive 
differentiation" hypothesis. The H-2 restriction of maturing T  cells was investigated 
primarily  in  experiments  using  bone  marrow  radiation  chimeras  with  or  without 
thymic  grafts,  both  in  T  cell-mediated  cytotoxicity  (3,  4)  and  in  T  helper  cell- 
dependent antibody responses (2, 5-11). Thymic environment during T  cell matura- 
tion also affected immune response (Ir) 1 gene function  (10,  11).  In studies set up in 
parallel  in  the  same  systems  or  in  other  systems,  tolerance  induced  by  neonatal 
tolerization, in contrast to bone marrow chimeras, was not usually found to unveil a 
T  cell repertoire specific for antigen in association with the tolerated allogeneic H-2 
antigens (7,  12), although exceptions were observed (13). 
We have studied the mechanisms of regulation of the immune response to myoglo- 
bin  (Mb), especially the cellular mechanisms of Ir gene control. We have found two 
H-2-1inked genes controlling both the T  cell proliferative response and the antibody 
response to Mb, mapping in different I subregions, I-A, and I-C, of the H-2 complex 
(14-16).  In  a  recent  study,  we  found  that  the  Ir gene  defect  correlated  with  the 
inability  of  (high  responder  ×  low  responder)  F1  T  cells  to  cooperate  with  low 
responder B cells, even in the presence of functional Fa antigen-presenting cells (APC) 
and even when the B cells could be demonstrated to be primed  (by their ability to 
receive help from carrier-specific T  cells).5  In all of these studies using high and low 
responder B cells and/or APC, the T  cells had to be F1 hybrids to avoid allogeneic 
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effects.  Therefore,  to  explore  directly  the  role  of helper  T  cells  in  the  response 
controlled by Ir genes, alloreactivity had to be eliminated.  The method we elected to 
use  was  neonatal  tolerization,  partly  to  avoid  the  effects  on  the  T  cell  repertoire 
previously  observed  in  radiation  chimeras,  as  noted  above.  Neonatal  mice  were 
injected  intravenously  with  F1  spleen  cells  and  the  collaboration  of T  cells  from 
tolerized mice with B cells from high responder, low responder, or F1 mice was studied. 
Not only did we find that  low responder  mice had T  cells competent  to help  the 
antibody response to Mb in vitro, but we found that this help was due to a repertoire 
in the tolerized low-responder mice specific for Mb in association with high responder 
alloantigens,  i.e., a  repertoire  for antigen plus allo-major histocompatibility complex 
(MHC), which we did not expect to find in the neonatally tolerant  mouse, in which 
the thymus is homozygous for the low responder H-2 haplotype. These observations 
are discussed in terms of the following questions:  (a)  Is the H-2 restriction  of helper 
T  cells exclusively determined by the thymic environment  in which T  cells differen- 
tiated and matured or also by the extrathymic environment?  (b)  Are there normally 
clones of T  cells specific for Mb in the context of the H-2 d high responder haplotype 
present in low responder mice, but masked by allogeneic effects? (c)  What is the role 
of helper T  cells in the genetic control of the response to Mb? 
Materials  and Methods 
Animals.  B10.D2/nSn,  B10.BR/SgSn,  B10.A(5R)/SgSn,  C57BL/10  Sn,  (B10.D2  × 
B10.BR) F1, and B6D2 F1 mice were obtained from The Jackson Laboratory, Bar Harbor, ME. 
The B10.HTT and (B10.D2  x  C57BL/10) F1 mice were bred by us, the former from breeding 
pairs obtained from Dr. David H. Sachs of the National Institutes of Health (NIH). Mice were 
8-16 wk of age at the first immunization. 
Antigens.  Sperm  whale  Mb  was  obtained  from  Accurate  Chemical  &  Scientific  Corp. 
(Westbury, NY). The major chromatographic component, IV, purified as described previously 
(14) by the method of Hapner et  al.  (17), was used throughout  these studies.  Fowl gamma 
globulin (chicken)  (FTG) from United States Biochemical Corp. (Cleveland, OH) was used. 
Mb  Coupling to  F'yG.  Preparation  of Mb-eoupled  FyG  (Mb-FTG)  was  performed  by  a 
modification of the method described by Schroer et al. (18). Two bifunetional reagents, methyl- 
4-mercaptobutyrimidate hydrochloride (MBI)  and  m-maleimido-benzoyl N-hydroxy-succini- 
mide ester (MBS)  (Pierce Chemical Co., Rockford, IL) were used to couple Mb to F'I~G; 2.4 mg 
of MBS in 0.12 ml of dimethylformamide (Pierce Chemical Co.) were added to 1/zmol of Mb 
in 0.8 ml of 0.1  M  sodium phosphate buffer (NaPi),  pH  7.1, and allowed to react for 1 h at 
20°C with occasional stirring. The Mb-MBS solution was dialyzed against 0.05  M  NaPi, pH 
7.1, for 1.5 h.  100 nmol of FyG was dissolved in 0.14 ml of 0.05 M  NaPi, pH 7.1, with 0.1 mM 
Dt-dithiothreitol (DTT) (Sigma Chemical Co., St. Louis, MO); 0.3 mg of MBI in 0.3 ml of 0.05 
M  NaPi,  pH  7.1, with  0.1  mM  DTT,  was added  to the  FyG solution. The  FyG and  MBI 
solution was allowed to react for 1 h at 20°C with occasional stirring under argon gas to reduce 
oxidation. The MB!-F7  G  solution was dialyzed against 0.05 M  NaPi, pH 7.1, with 0.01  mM 
DTT for 1.5 h under argon gas. After centrifugation of both MBS-Mb and MBI-FyG solutions, 
the MBI-FyG and MBS-Mb solutions were mixed and allowed to react for 3 h at 20°C under 
argon gas with occasional stirring.  The Mb-F'yG solution was kept  in 0.05  M  NaPi, pH  7. l, 
with 0.4 mM DTT, overnight to block residual active sites of maleimide on the MBS-Mb. The 
Mb-FTG was purified by gel filtration on Sephadex G75 (Pharmacia Fine Chemicals, Div. of 
Pharmacia Inc., Piseataway, N  J) to remove excess reactants. The sterilized Mb-FTG was stable 
and  stored  at  4°C  in  phosphate-buffered  saline  (PBS).  The  preparation  of Mb-FyG  used 
throughout these experiments was characterized as follows:  the molar substitution  of Mb to 
FyG was 1.5; the concentration of Mb was 0.53 mg/ml and that of FTG was 3.13 mg/ml. The 
concentrations specified  in the cultures are those of the FyG moiety. 
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or with 200 #g of Mb-coupled FyG (Mb-FyG) in PBS emulsified 1:1  in complete Freund's 
adjuvant (H37Ra; Difco Laboratories, Detroit, MI) in total volume of 0.1  ml/animal. 3 wk 
after immunization,  the mice were boosted intraperitoneally  with 0.1 #g of purified Mb or Mb- 
F,fl3 in PBS, and they were killed 1-2 wk later. 
Cell Culture.  The culture system,  modified from  that  of Mishell  and  Dutton  (19),  was 
described in a previous paper (16). Briefly,  2.5 ×  106 spleen cells from immunized mice were 
cultured with 1 or 0.1 #g/ml of Mb or 0.01 or 0.001 #g/ml of Mb-FyG in 1.5 ml of RPMI 1640 
medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) supplemented 
with  10%  heat-inactivated fetal calf serum  (FCS)  (Microbiological Associates,  Walkersville, 
MD),  100  U/ml penicillin, 100 #g/ml streptomycin, 2  mM L-glutamine, and 5  X  10  -5 M 
2-mercaptoethanol in flat-bottomed wells (3524; Costar, Data Packaging, Cambridge, MA) for 
10 d at 37°C, 6% CO2 on a rocking platform. On the 4th d, 1 ml ofsupernatant was exchanged 
for fresh medium. On the 10th d, culture supernatants were harvested to measure the secreted 
antibodies. 
Preparation of Spleen Cells.  Spleen cells were prepared by gentle teasing of spleens, using 
forceps,  in cold balanced salt  solution (BSS,  NIH  Media Unit). The cell suspensions were 
treated with ammonium chloride lysing buffer to lyse the erythrocytes, and were washed with 
RPMI 1640 medium containing 5% FCS. 
Preparation of T  Cells.  T  cells  were prepared  by passage of spleen cells  over nylon fiber 
columns (1 ×  108 cells/g of nylon) and collection ofnylon-nonadherent  eluate (20). Nonadherent 
cell populations were irradiated with 250 rad from a 137Cs source to eliminate memory B cells. 
Preparation of  B Cells and Accessoo~ Cells.  B cells and accessory cells were prepared by depleting 
splenic T  cells by treatment with a  rabbit antibody against mouse brain-associated antigen 
(RaMB) (Litton Bionetics, Kensington, MD) and guinea pig complement (Gp C') (Cedarlane 
low tox complement; Accurate Chemical & Scientific Corp.). 
Preparation of Splenic Glass-adherent Cells (SAC).  The  preparation of SAC  was  described 
previously (16). 
Sephadex GIO Passage.  Sephadex G10 (Pharmacia Fine Chemicals) passage of spleen cells 
was performed by a modification of the method described by Hodes et al. (21). Briefly, 3 ×  108 
cells in 4 ml BSS containing  8% FCS (BSS-FCS) were added to a 30-ml Sephadex G10 column, 
incubated at 37°C for 45 min, and eluted with warmed BSS-FCS, collecting the first  20 ml of 
effluent. These effluent cells were resuspended in BSS-FCS and loaded on the second Sephadex 
G10 column. After incubation, the first  20 ml of effluent was collected and resuspended in 
culture medium. 
Radioimmunoassayfor Antibody to Mb.  The assay of antibody to Mb in the culture supernatant 
was performed by a solid-phase radioimmunoassay technique as described elsewhere (16). 
Preparation ofNeonatally Tolerized Mice.  The method of Billingham et al. (22) was used. The 
neonatal mice were rendered tolerant by the intravenous injection of ~2 X  10  7 spleen cells from 
adult F1 hybrid donor mice during the first 24 h after birth. Tolerance to H-2 alloantigens was 
assessed by responsiveness to these antigens in mixed-lymphocyte reaction (MLR)  and cell- 
mediated lympholysis (CML). The resulting tolerized populations contained <5% Fa cells by 
indirect  immunofluorescence or  2-4%  detectable  by  the  fluorescence-activated cell  sorter 
(FACS)  using H-2-speeific  reagents. The indirect immunofluorescence  staining was generously 
performed by Dr.  Ronald E.  Gress,  NIH. The FACS studies were generously performed by 
Mrs. Susan O. Sharrow, NIH. 
Treatment of T Cells with Anti-H-2 Antibodies.  Nylon-fiber column-passed T cells were treated 
with antibodies to tolerated H-2 antigens and rabbit C' (Rb C') (Cedarlane low-tox complement, 
Accurate Chemical and Scientific Corp.). C57BL/10 T cells were incubated with a 1:60 dilution 
of  anti-H-2 a  antibodies  (4227:C57BL/10  anti-B10.D2,  titer  1:128),  B10.BR  T  cells  were 
incubated with a 1:400 dilution of anti-H-2 a [948:(C57BL/10 × A/J) F1 anti-B 10.D2 absorbed 
with B 10.BR, titer 1:1024], and B 10.D2 T cells were treated with a  1:32 dilution of anti-H-2  b 
(4241, B 10.D2 anti-B  10, titer 1:64), respectively, for 30 min at 37°C. After another incubation 
with Rb C' for 30  rain at  37°C,  these cells  were extensively washed out with RPMI  1640 
supplemented with 5% FCS and cultured with Mb. The antisera used were a generous gift of 
Dr. David H. Sachs,  NIH. 
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with 2,000  rad in 0.2 ml of Click's medium (NIH Media Unit) containing 2 mM glutamine, 
100  U/ml  penicillin,  100  pg/ml  streptomycin  (all from  Gibco Laboratories), 5  X  10  -5  M 
2-mercaptoethanol (Microbiological Associates) and 0.8%  fresh normal mouse serum. After 5 
d, 0.5 pCi (methyl-3H) thymidine ([nH]TdR, New England Nuclear, Boston, MA; sp act 6.7 
Ci/m  mole)  was  added,  and  after 4  additional h  at  37°C,  the cells were  harvested  in  an 
automated collecting device (Microbiological Associates). Proliferation was estimated by scin- 
tillation counting of the 3H incorporated into cellular DNA. All cultures were performed in 
flat-bottomed tissue culture plates (3596;  Costar). 
CML.  Cytotoxie T  lymphocytes were generated by suspending 4 ×  10  s responder cells in 2 
ml of minimum essential medium  (MEM)  (Flow Laboratories, Inc., Rockville, MD) supple- 
mented with FCS for 5 d in a 5% CO2 humidified air atmosphere with 3 ×  106 stimulator cells 
irradiated with 2,000  rad  (23).  This number of stimulator cells was found to be more than 
sufficient to elicit maximal CML reactivit~ in all strain combinations tested. After harvest,sthe 
cells were assayed for their ability to lyse  Cr-labeled 48-h concanavalin A blasts in a 4-h  Cr 
release assay. Responses are expressed as mean percent specific lysis of triplicate determinations; 
percent  specific  lysis  is  calculated  as:  (epm  experimental  -  cpm  medium  control)/(cpm 
maximum release -  cpm medium control). The CML was generously performed by Dr. Ronald 
E. Gress, NIH. 
Results 
Spleen Cells from Neonatally Tolerized Mice Were Unresponsive to  Tolerized H-2 Alloanti- 
gens.  To assess the tolerance of neonatally tolerized mice, their ability to respond to 
the tolerated alloantigens was assessed by means of MLR  and CML. An example is 
shown in Table I. Spleen cells from B10.D2  (H-2a), B10.A(5R)  (H-2~), and C57BL/ 
10  (H-2 n)  mice  neonatally  tolerized  with  B6D2  F1  (H-2 b×a)  spleen  cells  showed 
extremely low alloreactivity to (B10.D2  ×  C57BL/10)  Fx (H-2 a×b) stimulator cells in 
an MLR. The same lack of MLR  reactivity was demonstrable in other experiments 
using stimulator cells homozygous for the tolerated H-2 haplotype. The same cells did 
TABLE  I 
Assessment of Tolerance of NeonataUy Tolenzed  Mice 
Tolerized  Number of  MLR stimulator*  CML:~ 
with B6D2  Tolerated 
mice in  (BI0.D2 ×  SlCr  Responder  Fl spleen  alloantigens  pool  B 10.HTT  Stimulator  Target 
cells  C57BL/10)  Fi  release 
B1OD2§¶  +  H-2  h  6  159 (1.7)  5,459 (1.1)  B6D2 Fl  B6D2 Fa  3 (3) 
B 10.BR  B 10.BR  29 (7) 
BI0.A(SR)§¶  +  H-2K  d ~  I-E  d and  3  589 (1.3)  5,751  (I.1)  ND  n  ND 
H-2 I-J  b ~  D h 
C57BL/10§¶  +  H-2  d  6  372 (1.2)  7,279 (1.1)  B10.D2  B10.D2  7 (I.9) 
B 10.BR  BI0.BR  33 (8.8) 
C57BL/10§**  +  H-2  d  3  -39  (1.4)  25,540 (1.1)  BI0.D2  BI0.D2  4 (1) 
BI0.BR  B 10.BR  39 (7) 
(B10.D2  ×  C57BL/10)  -  -  7  -2,287 (I.1)  27,038 (1.1)  ND  ND 
F,§¶ 
BI0.HTT**  -  -  1  16,600 (1.1)  460 (1.2)  ND  ND 
C57BL/10**  -  -  1  ND  ND  BI0.D2  BIO.D2  31  (1.6) 
B10.BR  B10.BR  37 (8) 
BI0.D2**  -  -  1  ND  ND  B6D2 FI  B6D2 Fl  42 (4) 
* [3H]TdR incorporation mean A cpm (geometric SEM). The control incorporation without stimulator (medium alone) for each responder population 
was: BI0.D2, 62 cpm; BI0.A(5R),  761  cpm;  immune C57BL/10,  1,699 cpm;  nonimmune C57BL/10,  1,736 cpm;  (BI0.D2  ×  C57BL/10)  Fl, 4,283 
cpm; BI0.HTT,  1,269 cpm. 
~: Percent of maximum 5~Cr release (SEM) at effector/target  ratio 40:1. 
§ The cells used in this experiment were same source of cells used in the experiment of Fig. 2. 
¶ Immunized with Mb. 
][ Not done. 
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FIG.  l.  Low responder tolerized T cells help F, B cells. Mb-immune (B 10.D2 X B  10.BR) Fa spleen 
cells were pretreated with RaMB and Gp C' to eliminate T cells. Mb-immune spleen cells from 
BI0.D2 or B10.BR mice neonatally tolerized with (B10.BR × B10.D2) F] cells were passed through 
a nylon fiber column to eliminate B cells and irradiated with 250 rad from a 137Cs source for the 
purpose of eliminating memory B cells. The T cells from tolerized B  10.D2 or B  10.BR were cultured 
with B cells from (B10.D2 × B10.BR) F1 at the ratio of 1:2 in the presence of Mb, 0.1 #g/ml. The 
antibody concentrations, determined by solid-phase radioimmunoassay, are expressed as mean _+ 
SEM. 
respond to  third-party cells from  B10.HTT.  Furthermore, the cells from  B10.HTT 
responded to stimulator cells of (B10.D2 ×  C57BL/10)  F1. Therefore, the unrespon- 
siveness of the tolerized spleen cells was not due to the condition of the stimulator 
cells.  In addition, cytotoxicity against the tolerated alloantigens was assessed.  Cells 
from  these  mice neonatally tolerized  to  B6D2  F]  were  cocultured with  irradiated 
B6D2  F1,  B10.D2,  or  B10.BR  stimulator cells to  induce killer cells.  The cells from 
tolerized  mice killed the  third-party target,  B10.BR,  after  stimulation by  B10.BR 
cells.  In  contrast,  tolerized  B10.D2  cells  failed  to  kill  H-2 b  targets,  and  tolerized 
B10.A(5R)  or C57BL/10  cells failed to  kill H-2 a targets,  even when stimulated by 
excess stimulator cells. Therefore, combining the MLR and the CML data, the mice 
injected with semiallogeneic cells at birth became tolerant at least to class II alloan- 
tigens and probably to class I alloantigens as well on the donor cells. Analogous results 
were obtained for B10.BR and B10.D2 mice tolerized with  (B10.BR  ×  B10.D2)  F~ 
cells at birth. 
Tolerized Low Responder B I O.BR or C57BL/ l O T  Cells Help Ft B  Cells. 3  As shown in 
Fig.  1,  tolerized B10.D2  or B10.BR T  cells or  (B10.D2  ×  B10.BR)  F1  B  cells were 
unresponsive to  Mb  by themselves.  However,  when T  ceils  from  B10.D2  were  co- 
cultured with B  cells from F1,  B10.D2 T  cells helped F1  B  cells quite well. Because 
B10.D2 mice were shown to be high responders to Mb in vivo or in vitro (14-16), the 
ability of B10.D2  T  cells to help Fx  B  cells was  reasonably expected.  On the other 
hand, low responder B 10.BR T  ceils tolerized to H-2  a alloantigens also could help Fx 
s In the present paper we do not experimentally distinguish between B cells and APC. However, in a 
subsequent paper, we show that these effects involve  a2genetic restriction in T  cell-B cell interaction, 
whether or not they also involve a T celI-APC restriction. 796  MYOGLOBIN  LOW  RESPONDER  T  HELP  HIGH  RESPONDER  B  CELLS 
B  cells. Similar experiments were conducted with another strain combination,  (B 10.D2 
×  C57BL/10)  F1  B  cells  and  B10.D2,  B10.A(5R),  or C57BL/10  T  cells,  all tolerized 
to  alloantigens  on  B6D2F1  spleen  cell  (Figs.  2,  3).  C57BL/10  mice were  tolerized  to 
H-2 d  alloantigens,  and  B10.D2  mice  were  tolerized  to  H-2 b  alloantigens.  Similar 
results were obtained,  namely  that  tolerized  higher  responder  B 10.D2  T  cells,  as well 
as  T  cells  from  intermediate  responder  B10.A(5R)  and  low  responder  C57BL/10 
mice, could  help  (B10.D2  ×  C57BL/10)  F1 B  cells.  These  data  indicated  that  T  cells 
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Fxc.  2.  Mb-immune, not nonimmune, low responder tolerized T cells help FI B cells. B cells were 
obtained from Mb-immune (B10.D2  X C57BL/10)  F1 spleen cells  and T  cells from Mb-immune 
B10.D2  or C57BL/10,  or  nonimmune C57BL/10  spleen cells from mice tolerized  at  birth with 
(B6D2)  F1 spleen cells. The T  ceils were cultured with B cells at the ratio of 1:2 in the presence  of 
Mb, 1 p,g/ml (See legend to Fig.  1). 
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FI~.  3.  Low responder  tolerized T cells pretreated  with antibody to high responder  H-2 alloanti- 
gens to eliminate any F1 T cells from the tolerization still help F1 B cells. B cells were obtained from 
Mb-immune (B 10.D2 × C57BL/10) F1 spleen cells and T cells from B10.D2, B10.A(5R), or C57BL/ 
10 spleen cells  neonatally  tolerized  with B6D2  F1  spleen  cells.  T  cells  derived  from B10.D2  or 
b  d  C57BL/10 mice were pretreated  with anti-H-2  or anti-H-2  antibody and Rb C', respectively,  to 
eliminate contaminating chimeric F1 spleen cells. The T cells were cultured with B cells at the ratio 
of 1:2 in the presence ofMb,  1 ~g/ml (See legend to Fig.  1), YOICHI KOHNO AND JAY A. BERZOFSKY  797 
not only from high responder mice but also from intermediate or low responder mice 
can help F1 B cells in vitro. 
At this stage, several possible artifacts must be considered that could provide trivial 
explanations for these observations:  (a)  helper activity of tolerized low responder T 
cells  for  F1  B  cells  might  be  due  to  an  allogeneic  effect,  even  in  the  absence  of 
detectable MLR and CML reactivity; (b) the T  cell help in the spleen of tolerized low 
responder mice might not be due to homozygous low responder T  cells, but rather to 
F1 T  cells that were derived from the donor cells used in neonatal tolerization. These 
possibilities were tested in the following experiments. 
Evidence Against an Allogeneic Effect: Antigen-primed  T Cells Are Required for Help.  Mb- 
immune tolerized C57BL/10 T  cells help (B10.D2  ×  C57BL/10)  Fa B cells as noted 
above. However, nonimmune tolerized C57BL/10 T  cells could not help Fa B cells in 
producing  an  anti-Mb  response  (Fig.  2).  Because  the allogeneic effect should  have 
been the same in both cases, these data argue strongly against a  positive allogeneic 
effect as the source of the help.  However, one might argue that an allogeneic effect 
could enhance a  weak response due to antigen-primed T  cells. Therefore, we inten- 
tionally co-cultured FIB cells with untolerized Mb-immune low responder T  cells or 
untolerized nonimmune (normal) low responder T  cells in the presence of Mb to test 
the degree of allogeneic help that could be observed in this combination. F1 B cells co- 
cultured with either normal low responder T  cells or Mb immune (nontolerant)  low 
responder T  cells produced only a  very low antibody response to Mb in the culture 
supernatants,  and the response with immune T  cells was no greater than  that with 
nonimmune T  cells  (data not  shown).  Therefore,  any allogeneic help produced  by 
low  responder  T  cells  was  very small  and  was  not  enhanced  by antigen  priming. 
Taken together, these experiments demonstrate that the response to Mb by F1 B cells 
with the help of tolerized low responder T  cells was not due to an allogeneic effect. 
One additional piece of evidence against an allogeneic effect is presented below. 
T Cells in the Tolerized Low Responder that Help F1 B Cells  Were Not Derived from Donor 
F1  Cells.  To  study  the  existence  of  F1  spleen  cells  in  the  tolerized  spleen  cell 
populations, the phenotypes of spleen cells from tolerized mice were tested by indirect 
immunofluorescence or by an FACS  using H-2-specific reagents.  FACS  and  immu- 
nofluorescence staining were generously performed by Mrs. Susan O. Sharrow and by 
Dr. Ronald E. Gress, respectively. The spleen cells from neonatally tolerized mice at 
10 wk of age were found to be contaminated with <5% F1 cells (limit of detectability) 
by indirect immunofluorescence staining and with ~2-4% F1 cells by FACS analysis. 
However, no F1 cells could be detected in the thymus even by FACS analysis.  4 This 
evidence for peripheral chimerization without thymic chimerization agrees completely 
with the more extensive studies of Streilein et al. (25) on this subject. The presence of 
these F1 cells may be important during antigen priming in vivo. 
The existence of F1 cells in the spleen led to the concern  that the helper activity 
attributed  to low responder T  cells was really due to Fa cells. Two types of evidence 
mitigate strongly against this possibility. (a) When Mb-primed F1 T cells were titrated 
into nonimmune T  cells in various proportions, no help was observed at < 10% primed 
F~ cells  (data not  shown).  Because the contaminating F1  cells in  the tolerized  mice 
4  An occasional mouse showed some (2%) cells bearing F~ la antigens in the thymus, but no F1 cells 
bearing H-2 K/D antigens of the F~. This apparently paradoxical result could be explained by the uptake 
of F~ Ia antigens, but not K/D antigens, by the host thymus cells (24). 798  MYOGLOBIN  LOW RESPONDER T  HELP HIGH RESPONDER  B CELLS 
were  uniformly  <5%,  they  would  not  have  been  sufficient  to  generate  the  help 
observed.  (b)  A  more definitive experiment was  to eliminate  F1  cells  from the  low 
responder T  cell population by treatment with an anti-H-2 alloantiserum and C'. As 
shown  in  Fig.  3,  Mb  immune-tolerized  C57BL/10  T  cells  were  pretreated  with 
polyclonal antibodies to high responder H-2 u alloantigens and Rb C' before culture. 
Even though chimeric F1 cells in the tolerized cell population were eliminated by this 
treatment, tolerized low responder C57BL/10 T  cells could still help Fa B cells just as 
well as untreated T  cells. The same results were found when tolerized B 10.BR T  cells 
were treated with anti-H-2K a I-A u antisera before co-culture with (B 10.BR ×  B 10.D2) 
F1 B cells.  The help was not diminished by the treatment with alloantiserum plus C'. 
As  a  control,  Mb-immune  F1  T  cells  treated  with  the  same  antibody  to  H-2  a 
alloantigens and Rb C' under the same conditions were lysed >98% and lost all helper 
function  as  well.  Based  on  these  data,  as  antibodies  to  H-2  a  alloantigens  could 
eliminate  functional  Fa  T  cell  activity  (as  well  as  kill  >95%  of  F1  cells  by  dye 
exclusion), the T  cells in tolerized low responder mice that helped F1 B cells were not 
derived from donor F1 T  cells. 
How Can Low Responder T  Cells Interact with F1 B  Cells?  Tolerized low responder T 
cells  helped  F1  B  cells.  However,  it  was  not  clear  whether  low  responder  T  cells 
recognized F1 B cells via syngeneic low responder MHC antigens or high responder 
alloantigens.  To  elucidate  the  mechanism  of the  recognition  of F1  B  cells  by  low 
responder T  cells, tolerized low responder T  cells were co-cultured with B cells from 
F,  (H-2  dxb or d×k),  high  responder  (H-2d), or 10w responder  (H-2  b or k)  mice.  The low 
responder mice used as the B cell source were immunized with Mb-FTG  , because low 
responder B cells were possibly not primed with Mb when they were immunized with 
Mb alone. Low responder mice immunized with Mb-FyG instead of Mb produced a 
good response to Mb when they were cultured with Mb-F~  (Figs. 4-6). These data 
indicated  B  cells in  low responder were primed with  Mb.  Tolerized  low responder 
C57BL/10  T  cells  help  (B10.D2  X  C57BL/10)  F1  and  B10.D2  B  cells  but  not 
syngeneic low responder C57BL/10  B  cells  (Fig.  4).  As  a  control,  the  B10.D2  and 
C57BL/10  B cells from mice immunized with Mb-FyG both produced antibodies to 
Mb  in  the  supernatants  when  cultured  with  syngeneic FyG-primed T  cells  in  the 
presence of Mb-FTG (Fig.  4)  (data  for B10.D2  cultured  with  Mb-FyG not  shown). 
The unlikely possibility of allogeneic help due to residual T  cells in the B 10.D2 B cell 
population  was  excluded  by  mixing  the  B10.D2  and  B10  B  cell  populations.  No 
response  was  seen  in  these  mixtures  without  added  T  cells.  Similarly,  neonatally 
tolerized low responder B 10.BR T  cells helped high responder B 10.D2 B cells but not 
syngeneic B10.BR B cells, both of which were immunized with Mb-FyG (Fig. 5). 
High Responder T  Cells  Tolerized to Low Responder MHC Fail To Help Low Responder B 
Cells and APC.  It has been reported  (26)  that removal of alloreactivity by negative 
selection  with  bromodeoxyuridine  and  (BUdR)  light  unmasks  a  responder  T  cell 
population  that  can  proliferate  in  response  to  antigen  presented  on  low  responder 
APC. We wanted to see whether higher responder B 10.D2 T  cells, neonatally tolerized 
to lower responder B 10.BR (H-2 k) alloantigens, would help B 10.BR B cells and APC. 
The result  (Fig.  6)  was that such B10.D2 T  cells did not  help B10.BR  B cells, even 
though the latter were adequately primed as demonstrated by their response to Mb- 
FyG.  An  additional  result  of this  experiment  was  to  lend  further  support  to  the 
conclusion above that the help observed was not due to positive allogeneic effects. In 3
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FIG.  5.  Low responder B10.BR neonatally tolerized T  cells help high responder but not syngeneic 
low responder B cells. B cells were obtained from Mb-F~3 immune B 10.D2 or B 10.BR spleen cells 
and T cells from Mb-immune tolerized B 10,BR spleen cells. T  cells were cultured with B cells at the 
ratio of 1:2 in the presence of Mb, 1 Vtg/ml ([S]). Mb-F';tG immune B 10.BR spleen cells treated with 
Gp C' alone were cultured with Mb-FTG, 0.01 ~g/ml (Ira). (See legend to Fig.  1.) 
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Fic.  6.  High responder tolerized T  cells help F~ B cells but not low responder B cells. B ceils were 
obtained from Mb-immune (B10.D2 X B10.BR) F1 or Mb-FyG immune B10.BR spleen cells and T 
cells from Mb-immune tolerized B10.D2 spleen cells. T  cells were cultured with B cells at the ratio 
of 1:2 in the presence of Mb,  1 ~g/ml ([~).  Mb-FyG-immune B10.BR spleen cells treated with Gp 
C' alone were cultured with Mb-FyG, 0.001 gg/ml (m). (See legend to Fig.  1.) YOICHI KOHNO AND JAY  A.  BERZOFSKY  801 
contrast to the tolerized low responder T  cells, which help allogeneic high responder 
and  F1  B  cells  and  APC,  but  not  syngeneic B  cells  and  APC,  the  tolerized high 
responder  T  cells  help  syngeneic  B  cells  and  semiallogeneic  F1  B  cells,  but  not 
allogeneic low  responder B  cells  and  APC.  Thus,  the  response  depends  on  the  Ir 
genotype of the B eell/APC source, not on its allogenicity relative to the T cell source. 
From all of these data together, we conclude that tolerized low responder T  cells, like 
tolerized high responder T cells, can recognize Mb in the context of the high responder 
but not the low responder MHC antigens on the F1 B cells. 
Low  Responsiveness of Low  Responder B  Cells Is  Not  Due  to  Suppressor Cells  in  This 
Population.  To test for the possibility that  the failure of low responder B cells and 
APC to receive help was due to the presence of suppressor cells in the low-responder 
B cell population, we co-cultured these low responder B cells with unseparated, Mb- 
immune F1 spleen cells (last three bars of Fig. 4). No suppression was observed at any 
ratio of low responder B cells to F1 spleen cells. Therefore, the failure of low responder 
B cells to respond is not due to suppressor cells in their midst  (unless the suppressor 
cells can act only on low responder B cells--a possibility that cannot be completely 
excluded, but which we think unlikely because such postulated suppressor cells cannot 
be detected when the same B cells are responding to FyG-specific help (Fig. 4, fourth 
column  from  right). 5 As  another control  for T  cells  in  the  B  cell  population,  no 
allogeneic help could be demonstrated when these low responder B cells were mixed 
with Mb-primed B 10.D2 B cells in the absence of exogenous helper T  cells (data not 
shown). 
Discussion 
The data presented here indicated that clones of helper T cells specific for Mb exist 
in low responder mice and that these low responder T  cells can collaborate with high 
responder B cells when alloreactivity is eliminated. At least two mechanistic questions 
arise.  (a) How do these helper cells arise in the repertoire? (b) How are they primed 
to  be  specific  for  Mb  in  the  context  of alloantigen?  The  former,  more  difficult, 
question is addressed below. The latter question, we believe, is more straightforward. 
Because we can detect 2-4% chimerization by F1 cells in the spleens of the tolerized 
mice, we believe these may be sufficient during immunization in vivo for clones of T 
cells restricted to the high responder alloantigens (H-2 a) to be primed. Using a FACS, 
we consistently observed 2-4% F1 cells in the spleens of neonatally tolerized mice at 
10-16 wk of age. In contrast, in most of the mice we could detect no F1 cells in the 
thymus (see below).  4 Similarly, Streilein et al.  (25)  have reported detecting variable 
chimerization, from 0.2 to 4.0% FI cells in the spleen, but none detectable (<0.1%) in 
the thymus. 
It might be argued that the collaboration across H-2 barriers reported here could 
be due to an allogeneic effect (28-30), even though no alloreactivity could be detected 
by MLR or CML (Table I  [31]).  We can exclude this possibility as follows: nonim- 
mune low responder tolerized T  cells could not  help Fa B  cells, and  immune high 
responder tolerized T cells could not help low responder B cells. If a positive allogeneic 
effect were the cause of our results, one or both of these controls should have been 
5 Suppression was assessed only in a secondary response. Although suppressor cells  have been reported 
which act only on a primary response (27), these could not account for our results, which all were obtained 
in secondary responses. 802  MYOGLOBIN  LOW RESPONDER T  HELP HIGH RESPONDER B CELLS 
positive. Furthermore, under our culture conditions, little or no allogeneic help could 
be elicited even intentionally. 
Another trivial explanation would be that  the help is produced not  by the  low 
responder  T  cells  themselves,  but  by  high  responder  F1  T  cells  chimerizing  the 
tolerized host.  Even  though chimerization was  <5%,  this was  still  a  concern. The 
evidence against it is twofold: (a) the helper T  cells from low-responder tolerized mice 
pretreated with antibodies to alloantigens and complement, to abolish contaminating 
chimeric F1 cells, could still help F1 B cells;  (b) in these culture conditions, a ratio of 
T cells to B cells of < 1:3 or :4 did not result in antibody production (16). Furthermore, 
if varying ratios of Mb-primed F1 T  cells were mixed with unprimed F1 T  cells and 
help for syngeneic F1 B cells assessed, 5% primed T  cells were insufficient to produce 
help  for a  response to Mb.  In other words,  a  contamination with  <5%  F1 T  cells 
would not have been sufficient to produce the help observed. From these two different 
sorts  of experiments,  it  is  very  unlikely  that  contaminating  chimeric  F1  T  cells 
provided the help for F1 B cells. 
Having ruled out  these two artifactual  explanations  of our results, we conclude 
that the present results demonstrate that genotypic low responder (H-2 k or 1-1-2 b)  T 
cells neonatally tolerized to higher responder H-2 a antigens can provide Mb-specific 
help for high responder H-2 a B cells and APC. Two types of explanations are possible 
for the existence of these helper T cells specific for antigen in the context of allogeneic 
MHC  antigens.  (a)  Such cells may be present normally in low responder mice but 
masked by allogeneic effects. When alloreactivity is removed, they are unmasked and 
can be detected. (b) The process of neonatal tolerization may actually expand the T 
cell repertoire at the same time that alloreactivity is eliminated. 
The first type of explanation, that such cells are normally present but masked by 
allogeneic effects, can be broken down further into two possibilities. First, it is possible 
that the repertoire is normally present in all animals for most antigens in the context 
of most haplotypes. This concept would be consistent with several studies in which 
alloreactivity was  acutely depleted  (26,  32,  33).  The second possibility  is  that  the 
repertoire for reactivity across allogeneic barriers occurs only for certain combinations 
of antigen and  foreign MHC, because these combinations cross-react with another 
antigen in association with self-MHC  (i.e., Mb  plus H-2 d  is  recognized as a  cross- 
reaction by T  cells really specific for H-2 k plus some other antigen [X]). This idea is 
consistent with the observations of Doherty and Bennink (34, 35). However, it has at 
least two problems. First, it would require that such an exceptional case apply to both 
1t-2 b and 1t-2 k low responders, suggesting that it may not be so exceptional a situation. 
Second, it requires the implicit assumption that what is recognized is a neoantigenic 
determinant  formed  between  H-2 d  and  Mb,  which  can  cross-react  with  another 
neoantigenic determinant formed between H-2 k and antigen X  or between 1-1-2 b and 
antigen Y. It is less compatible with mechanisms involving dual recognition of antigen 
plus MHC, or even less stringent "altered self" hypotheses (1). 
The second type of explanation, namely that the process of neonatal tolerization 
actually expands the T  cell repertoire, can also be divided into two subcategories-- 
intrathymic and extrathymic mechanisms. First, it is possible that neonatal toleriza- 
tion by injection of adult F1 spleen cells at birth alters the T  cell repertoire by altering 
the  thymic environment.  This  mechanism  would  be  consistent  with  observations 
made  in bone marrow chimeras  (1,  5,  10,  11),  except that  the  thymic component YOICHI KOHNO AND JAY A. BERZOFSKY  803 
bearing the foreign MHC antigens could not be the thymic epithelium, as has been 
suggested, but would have to be circulating cells, such as lymphocytes or macrophages 
of the donor, which could enter the host thymus, in agreement with the observations 
of Longo and Schwartz (36) in chimeras. However, Streilein et al. (25) have observed 
chimerization only in the periphery, not in the thymus, in mice neonatally tolerized 
by a  procedure similar to ours. To test this question in our own mice, we examined 
tolerized animals by use of the FACS at the time of the culture experiments. Although 
most mice showed 2-4% peripheral chimerization with F1 cells in the spleen, only rare 
mice showed detectable F1 cells in the thymus. This result makes this mechanism less 
likely, but it remains a possibility, as we cannot exclude the presence of F1 cells in the 
thymus below our limits of detection, or during a short period after tolerization. 
Second, if neonatal tolerization leads to an alteration of T  cell repertoire without 
chimerization of the thymus, it is possible that the repertoire is developed extrathy- 
mically. This possibility is compatible with the observation of  peripheral chimerization 
without thymic chimerization. Moreover, there is precedent for such a suggestion in 
the studies of cytotoxic T  cells in thymus-engrafted nude mice by Zinkernagel et al. 
(37),  Lake  et  al.  (38),  and  Kruisbeek et  al.  (39).  It  is  more  difficult, however, to 
reconcile extrathymic repertoire development with the contraction of the repertoire 
in F1 ~  parent bone marrow chimeras despite peripheral F1 cells (1-6, 9,  10, 40, 41), 
or with the restriction to the thymic parental haplotype of helper cells from ~  nude 
mice engrafted with a  parental thymus  (42)  and homozygous nude mice engrafted 
with an allogeneic thymus (43). 
Thus, whether intrathymically or extrathymically, the act of neonatal tolerization 
could have altered the T  cell repertoire of such tolerant mice to include clones of T 
cells capable of cooperating with high responder B cells and APC. The current study 
cannot distinguish these mechanisms from each other or from the possibility that the 
repertoire of T cells capable of cooperating with high responder B cells and APC may 
normally be present in the low responder mouse, but just masked by alloreactivity. 
Although our results agree with those of Forman et al.  (13) in the cytotoxic T  cell 
response of neonatally tolerized mice, they appear to be somewhat discrepant with 
the results for neonatally tolerized mice in a virus-specific cytotoxic response (12, 40), 
and with those for the antibody response of cells acutely depleted of alloreactivity by 
filtration through an irradiated F1 host  (44,  45). The 1-1-2 K/D-restricted  cytotoxic 
responses may not be directly comparable to the Ia-restricted antibody responses as 
these repertoires may be affected differently by neonatal tolerization (25, 46) (as well 
as  in  bone  marrow chimeras  [43]).  In  the  case of the  antibody response  to sheep 
erythrocytes studied by Sprent and von Boehmer (44), the differences may be caused 
by differences in the method of tolerization. On  the one hand,  the acute depletion 
method may also remove some of the repertoire for exogenous antigen seen in the 
context of the tolerated Ia. On the other hand, long-term tolerance from birth may 
allow the emergence of a  repertoire not  unmasked  by the short-term  depletion  of 
alloreactive cells immediately before experimental culture. Finally, neonatal toleri- 
zation may possibly alter the repertoire, as discussed above. 
Besides the chimera studies and acute depletion studies mentioned above, there are 
a  few other studies in the literature that  suggest  that  low responder T  cells can be 
elicited for a response to the antigen under lr gene control if they are immunized or 
induced by the proper route. For instance, Pierce and Kapp (47) showed that helper 804  MYOGLOBIN  LOW RESPONDER T  HELP HIGH RESPONDER B CELLS 
T  cells specific for L-glutamic acid6°-L-alaninen°-L-tyrosinel° (GAT) on low responder 
APC  could be elicited by immunizing F1  mice with antigen bound to those APC. 
Araneo et al. (48) found helper T  cells for a lysozyme response in the popliteal lymph 
nodes of low responder mice early but not late in the course of the response. However, 
both the GAT and lysozyme responses involve active suppression in the low responder. 
Nevertheless, even  for cases  in  which  no suppression  has  been  demonstrable  as  a 
mechanism  of Ir  gene  control,  such  as  responses  to  (T,  G)-A--L  (49),  T6-A--L, 
(H, G)-A--L (50), and IgG myeloma protein (51), the elicitation of helper T  cells in 
low responders has been possible by various manipulations. 
Finally, our observation that high responder T cells tolerant to low responder MHC 
antigens cannot help low responder B cells and APC appears to be in disagreement 
with  the observation of Ishii et al.  (26)  that  acute depletion of alloreactivity with 
BUdR and light allows responder T cells to proliferate in response to antigen presented 
on low responder APC. One difference may be that the secondary antibody response 
we are studying involves a  T  cell-B cell restriction as well as a  possible T  cell-APC 
restriction, in contrast  to the proliferative response which involves only the latter. 2 
However, a  second difference between our results lies in the methods of removal of 
alloreactivity. Treatment of alloreactive cells undergoing an MLR with BUdR results 
in uptake of the BUdR into the DNA of the dividing cells.  Subsequent exposure to 
ultraviolet light produces cross-linking of the DNA and thus prevents further repli- 
cation. Although these cells cannot proliferate again in a  secondary MLR, they are 
not necessarily killed, and may still carry out functions not requiring replication, such 
as positive allogeneic effects which may enhance weak antigen-specific proliferative 
responses caused by residual high responder APC. Moreover, the T  cell proliferative 
response may be more susceptible to such positive allogeneic effects than the secondary 
in vitro antibody response, which in our hands is rather insensitive to such effects. 
It should also be pointed out that these results agree with some of the findings of 
Pierce et al. (52) but not others. These investigators studied allogeneic mixes of T cells 
and B cells in an Ir gene-controlled antibody response in a splenic fragment culture 
system. In our system, as in theirs, low responder T  cells could collaborate with high 
responder B cells but not with low responder B cells.  The only discrepancy between 
the two studies  is that we do not  find that  high responder T  cells, tolerant to low 
responder  MHC,  help  low  responder  B  cells.  One  difference was  that  their  low 
responder B cells were specific for a hapten, not for the antigen under Ir gene control 
as in the present study. However, the difference also may be caused by the fact that 
in the splenic fragment system, no specific attempt was made to remove alloreactivity. 
Thus, the response observed could have been influenced by positive allogeneic effects, 
although controls were done to suggest otherwise. On the other hand, the hypothesis 
of Pierce et al.  (52)  predicts that  specific tolerization of the high responder to low 
responder alloantigens would eliminate the repertoire they described for antigen in 
the context of low responder alloantigens. Thus, it can never be tested, by definition, 
in the absence of possible allogeneic effects (and for the same reason, is not actually 
incompatible with our results). 
How do these results help us to pinpoint the Ir gene defect for the antibody response 
to Mb? Because low responder B cells can be primed to Mb by using Mb-FyG and 
produce anti-Mb in the presence of FyG-specific help, we know that the low responder 
has competent Mb-specific B cells. In this study, we also found competent Mb-specific YOICHI KOHNO AND JAY A.  BERZOFSKY  805 
helper T  cells  in  the  low responder,  which  were not  phenotypically different  from 
those in the high responder, in that both helped only high responder or Fa B cells and 
APC, not low responder B cells and APC. Thus, the defect may be in neither the T 
cell nor the B cell alone, but in the interaction between low responder T  cells and low 
responder B cells and APC, or may reflect selective priming of helper cells by APC 
during in vivo immunization, which is then mirrored by a  T  cell-B cell restriction in 
vitro. In a subsequent  paper, we will demonstrate that at least one defect exists in T 
cell-B cell collaboration, independent of the source of APC. 2 
Summary 
We sought to examine the role of immune response (Ir) genes in helper T  cells. To 
eliminate allogeneic effects, we used neonatally tolerized mice. The results bear not 
only  on  the  mechanism  of lr  genes,  but  also  on  the  development  of the  T  cell 
repertoire. B 10.BR  (H-2 k) or C57BL/10  (H-2 b)  ix.ice,  which were low responders to 
myoglobin (Mb), were neonatally tolerized to high responder H-2 a alloantigens, and 
B10.D2  mice, which  were high  responders  to Mb,  were neonatally tolerized  to low 
responder H-2 k or H-2 b alloantigens.  Spleen cells from these tolerized mice did not 
show  any  reactivity  in  mixed-lymphocyte  reaction  or  cell-mediated  lympholysis 
against alloantigens used in tolerization. Mb-immune F1 B cells were helped compar- 
ably by Mb-immune tolerized low or high responder T  cells. Thus, low responder T 
cells functioned equivalently to high responder T  cells.  The failure of nonimmune T 
cells from tolerized low responder mice to help F1 B cells and antigen-presenting cells 
(APC)  indicated  that collaboration between B10.BR or C57BL/10  T  cells and F1  B 
cells was not caused  by a  positive allogeneic effect. Spleen cells from tolerized mice 
were contaminated with 2-4% chimeric F1 cells, as judged by fluorescence-activated 
cell sorter analysis, and no Fa alloantigens were detectable in the thymus.  However, 
removal of chimeric F~ T  cells from the tolerized cell population  by treatment with 
anti-H-2 and complement did not change the helper activity of tolerized low responder 
T  cells.  These data indicated  that helper activity in  the T  cell population  from low 
responder  mice was  not  due  to  F~  cells.  Also,  the  level  of contamination  was  not 
sufficient to quantitatively account for the help. In examining the genetic restriction 
of these tolerized T  cells, we found that T  cells from tolerized low responder B 10.BR 
or C57BL/10  mice helped  F1  or high  responder  B10.D2  B  cells  and  APC  but  not 
syngeneic B10.BR or C57BL/10 B cells and APC, which were immunized with Mb- 
coupled fowl gamma globulin instead of Mb to prime low responder B cells with Mb. 
On the other hand, high responder B 10.D2 tolerized T  cells helped syngeneic B 10.D2 
B cells but not allogeneic low responder B10.BR B cells. 
These  data  indicated  that  clones  of helper  T  cells  specific  for Mb  exist  in  low 
responder  mice,  and  these  are  not  phenotypically  different  from  those  in  high 
responder mice, in that both help high responder and Ft but not low responder B cells 
and APC. These data are discussed in terms of the mechanism for Ir gene control, and 
the mechanism of T cell repertoire development--whether intra- or extrathymically-- 
in neonatally tolerized mice. 
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